The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
aTyr Pharma Inc | COM | 002120202 | 4,197,000 | 1,398,889 | SH | SOLE | 1,398,889 | 0 | 0 | |||
Aclaris Therapeutics Inc | COM | 00461U105 | 71,837,000 | 4,563,962 | SH | SOLE | 4,563,962 | 0 | 0 | |||
Aerovate Therapeutics Inc | COM | 008064107 | 13,827,000 | 833,927 | SH | SOLE | 833,927 | 0 | 0 | |||
Affimed NV | COM | N01045108 | 2,943,000 | 1,428,571 | SH | SOLE | 1,428,571 | 0 | 0 | |||
Akouos Inc | COM | 00973J101 | 18,932,000 | 2,800,566 | SH | SOLE | 2,800,566 | 0 | 0 | |||
Altimmune Inc | COM | 02155H200 | 4,716,000 | 369,306 | SH | SOLE | 369,306 | 0 | 0 | |||
Annexon Inc | COM | 03589W102 | 19,900,000 | 3,220,050 | SH | SOLE | 3,220,050 | 0 | 0 | |||
Celldex Therapeutics Inc | COM | 15117B202 | 2,108,000 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
Cogent Biosciences Inc | COM | 19240Q201 | 60,249,000 | 4,038,117 | SH | SOLE | 4,038,117 | 0 | 0 | |||
Dice Therapeutics Inc | COM | 23345J104 | 15,514,000 | 764,979 | SH | SOLE | 764,979 | 0 | 0 | |||
Fulcrum Therapeutics Inc | COM | 359616109 | 9,708,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | |||
GH Research PLC | ORD SH | G3855L106 | 38,731,000 | 3,333,154 | SH | SOLE | 3,333,154 | 0 | 0 | |||
Gossamer Bio Inc | COM | 38341P102 | 20,929,000 | 1,747,000 | SH | SOLE | 1,747,000 | 0 | 0 | |||
Immunocore Holdings PLC | ADS | 45258D105 | 4,441,000 | 94,605 | SH | SOLE | 94,605 | 0 | 0 | |||
Inozyme Pharma Inc | COM | 45790W108 | 7,263,000 | 2,709,987 | SH | SOLE | 2,709,987 | 0 | 0 | |||
Instil Bio Inc | COM | 45783C101 | 19,872,000 | 4,105,779 | SH | SOLE | 4,105,779 | 0 | 0 | |||
LianBio | SPONS ADR | 53000N108 | 10,757,000 | 5,378,341 | SH | SOLE | 5,378,341 | 0 | 0 | |||
Lyra Therapeutics Inc | COM | 55234L105 | 4,630,000 | 924,170 | SH | SOLE | 924,170 | 0 | 0 | |||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 20,993,000 | 3,156,803 | SH | SOLE | 3,156,803 | 0 | 0 | |||
Milestone Pharmaceuticals Inc | COM | 59935V107 | 22,293,000 | 2,425,737 | SH | SOLE | 2,425,737 | 0 | 0 | |||
Pliant Therapeutics Inc | COM | 729139105 | 22,561,000 | 1,080,000 | SH | SOLE | 1,080,000 | 0 | 0 | |||
Prometheus Biosciences Inc | COM | 74349U108 | 7,179,000 | 121,663 | SH | SOLE | 121,663 | 0 | 0 | |||
Provention Bio Inc | COM | 74374N102 | 5,034,000 | 1,118,653 | SH | SOLE | 1,118,653 | 0 | 0 | |||
Rallybio Corp | COM | 75120L100 | 3,886,000 | 268,532 | SH | SOLE | 268,532 | 0 | 0 | |||
Relmada Therapeutics Inc | COM | 75955J402 | 56,198,000 | 1,518,056 | SH | SOLE | 1,518,056 | 0 | 0 | |||
Savara Inc | COM | 805111101 | 7,060,000 | 4,555,038 | SH | SOLE | 4,555,038 | 0 | 0 | |||
Terns Pharmaceuticals Inc | COM | 880881107 | 21,839,000 | 3,707,891 | SH | SOLE | 3,707,891 | 0 | 0 | |||
Trevi Therapeutics Inc | COM | 89532M101 | 4,697,000 | 3,050,022 | SH | SOLE | 3,050,022 | 0 | 0 | |||
Tricida Inc | COM | 89610F101 | 94,845,000 | 9,050,064 | SH | SOLE | 9,050,064 | 0 | 0 | |||
Ventyx Biosciences Inc | COM | 92332V107 | 7,259,000 | 207,925 | SH | SOLE | 207,925 | 0 | 0 | |||
Viridian Therapeutics Inc | COM | 92790C104 | 43,693,000 | 2,130,308 | SH | SOLE | 2,130,308 | 0 | 0 |